Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - TOTAL CURRENT LIABILITIES
Total Current Liabilities IBRX - ImmunityBio, Inc.
58.3 M
LAST VALUE
-60.26%
2 YEAR CAGR
16.41%
5 YEAR CAGR
27.84%
10 YEAR CAGR